畅脉乐胶囊临床合理用药分析  

Analysis on Clinical Rational Drug Use of Changmaile Capsules

作　　者：张宽[1] 翁一玲[1] 张瑜[1] 严锦贤[1] 曾茂贵[1] 

机构地区：[1]福建中医药大学附属第二人民医院药学部,福建 福州

出　　处：《中医学》2023年第3期496-501,共6页Traditional Chinese Medicine

摘　　要：目的:调查我院中药院内制剂畅脉乐胶囊(I)临床应用现状,为其临床合理应用提供参考。方法:采用回顾性分析,随机抽取病历100例,对其基本信息、适应症、用法用量、联合用药、不良反应等进行分析总结。结果:患者主要为老年患者,畅脉乐胶囊(I)主要用于高血压、糖尿病、脑梗死、冠心病等疾病的治疗,多与他汀类等西药联合应用;医嘱合理率为89%,不合理主要是用药与辨证不符;暂无不良反应报告。结论:畅脉乐胶囊(I)临床疗效确切,临床应用存在不合理现象,临床医生应根据患者的具体情况进行评估,规范其合理使用。Objective: To investigate the clinical application status of Changmaile Capsules (I), a traditional Chinese medicine preparation in our hospital, and to provide reference for its clinical rational application. Methods: Retrospective analysis was used to randomly select 100 cases of medical records, and their basic information, indications, usage and dosage, combined medication, and adverse reactions were analyzed and summarized. Results: The patients were mainly elderly pa-tients. Changmaile Capsules (I) were mainly used for the treatment of hypertension, diabetes, cerebral infarction, coronary heart disease and other diseases, and were mostly used in combination with western medicines such as statins. The reasonable rate of doctor’s orders was 89%, which was unreasonable. The main reason is that the medication does not match the syndrome differentiation;there is no adverse reaction report. Conclusion: Changmaile Capsule (I) has definite clinical curative effect, but there are unreasonable phenomena in clinical application. Clinicians should evaluate it according to the specific conditions of patients and standardize its rational use.

关 键 词：畅脉乐胶囊(I) 联合用药 临床疗效 用药分析 

分 类 号：R28[医药卫生—中药学]